Triple
T13942317
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Pfizer–BioNTech |
E335285
|
entity |
| Predicate | isCommercialCollaborationBetween |
P112359
|
FINISHED |
| Object | Pfizer and BioNTech SE |
E335285
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Pfizer and BioNTech SE | Statement: [Pfizer–BioNTech, isCommercialCollaborationBetween, Pfizer and BioNTech SE]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Pfizer and BioNTech SE Context triple: [Pfizer–BioNTech, isCommercialCollaborationBetween, Pfizer and BioNTech SE]
-
A.
Pfizer–BioNTech
chosen
Pfizer–BioNTech is a pharmaceutical partnership best known for developing one of the first widely authorized mRNA vaccines against COVID-19.
-
B.
BioNTech
BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
-
C.
Moderna
Moderna is a biotechnology company best known for pioneering mRNA-based vaccines, including one of the first widely used COVID-19 vaccines.
-
D.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
E.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: isCommercialCollaborationBetween Context triple: [Pfizer–BioNTech, isCommercialCollaborationBetween, Pfizer and BioNTech SE]
-
A.
isCollaboration
Indicates that two or more entities are jointly working together toward a shared goal or producing something in partnership.
-
B.
collaborationOf
Indicates a relationship in which two or more entities work together jointly toward a shared goal or outcome.
-
C.
establishedInCollaborationWith
Indicates that something was created, founded, or set up jointly through cooperative effort between two or more parties.
-
D.
isCollaborative
Indicates that two or more entities work together jointly toward a shared goal or outcome.
-
E.
isCommercialCommunityFor
Indicates a relationship where one entity serves as the primary commercial hub or marketplace community for another entity (such as a product, brand, or user group).
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d81c6081b88190b53e317c3370c8fe |
completed | April 9, 2026, 9:38 p.m. |
| NER | Named-entity recognition | batch_69de2e0f6f3c8190a64058b732b0ac52 |
completed | April 14, 2026, 12:07 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69fbc3201af48190a1746abbf080187d |
completed | May 6, 2026, 10:39 p.m. |
| PD | Predicate disambiguation | batch_69de05a3ccf88190b45c742db483fa08 |
completed | April 14, 2026, 9:15 a.m. |
| PDg | Predicate description generation | batch_69de239524688190a0f2408c239cfcaa |
completed | April 14, 2026, 11:23 a.m. |
Created at: April 9, 2026, 10:17 p.m.